The Conundrum of Treating de novo metastatic Hormone-Sensitive Prostate Cancer

Abstract With the heterogeneous use and interpretation of next-generation molecular imaging and approval of new treatment strategies, therapeutic decision-making for de novo metastatic hormone-sensitive prostate cancer (mHSPC) is becoming increasingly challenging. It is conceivable that patients are...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Tessa van Elst, Niven Mehra, Sjaak Bloem, André N. Vis, Bart P. Wijsman, Daphne Luijendijk-de Bruin, Joyce M. van Dodewaard-de Jong, Pieter L. van den Berg, Jules Lavalaye, Shafak Aluwini, Derya Yakar, Daniela E. Oprea-Lager, Peter F. A. Mulders, Haiko J. Bloemendal, Jean-Paul A. van Basten
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Nature Portfolio 2025-04-01
Edice:	Scientific Reports
Témata:	Metastatic hormone-sensitive prostate cancer Imaging Treatments Guidelines Practice variation
On-line přístup:	https://doi.org/10.1038/s41598-025-96065-9
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!